Alvotech Investigated For Potential Securities Law Violations by Block & Leviton LLP; Investors Who Have Lost Money Are Encouraged to Contact the Firm
April 14, 2023 11:22 ET
|
Block & Leviton LLP
BOSTON, April 14, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Alvotech (NASDAQ: ALVO) for potential securities law violations. Investors who have lost money in their Alvotech...
Insights on the Ankylosing Spondylitis Global Market to 2030 - Rise in Number of Hospitals and Diagnostic Centers is Driving Growth
May 05, 2022 08:08 ET
|
Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Market by Drug Class and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
Coherus Highlights Anticipated New Product Launches and Immuno-oncology Growth Strategy at Analyst Day Event
March 29, 2022 09:15 ET
|
Coherus BioSciences, Inc.
— Multiple near-term anticipated product launches and development of innovative immuno-oncology pipeline position Coherus for long-term growth – — Introducing 2026 revenue target of $1.2...
Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
December 20, 2021 07:59 ET
|
Coherus BioSciences, Inc.
- Approved for all eligible indications of the reference biological product, Humira® (adalimumab) - - YUSIMRY is Coherus' second FDA-approved product - REDWOOD CITY, Calif., Dec. 20, 2021 (GLOBE...
HUMIRA (Adalimumab) Biosimilars Market Report 2021: Current Developer Landscape and Clinical Research Scenario Related to All the Follow-on Products of the Blockbuster Biologic Drug
July 30, 2021 06:03 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "HUMIRA? (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
February 17, 2021 07:30 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that the United States Food and Drug Administration (“FDA”) has...
Global Ankylosing Spondylitis Market Outlook Report 2019-2027: Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities
December 21, 2020 10:53 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...
Global Ankylosing Spondylitis Market Outlook to 2027: High Treatment Cost and Lack of Skilled Surgeons and Physiotherapists are Hampering Market Growth
November 04, 2020 04:43 ET
|
Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...